Request For Applications Announcement

Developmental Core Requests Applications for Developmental Grants

The University of Miami Miller School of Medicine Developmental Center for AIDS Research (DCFAR) is requesting applications for developmental grants.  The purpose of this grant program is to provide seed money to stimulate new research and new collaborations in HIV/AIDS.  These funds are provided for support of a) pilot research projects conducted by young investigators or investigators new to the field of HIV/AIDS.  b) New and innovative projects from new or established investigators. c) New collaborative research projects that are conducted between two different disciplines and/or different departments.  

Information about the Application Process

Due date:  October 15, 2008 at 5:00 PM. 

Send the application and all other forms by email in PDF format c/o Ms. Jeanne Tamargo, DCFAR Administrator at  jtamargo@med.miami.edu.

Eligibility:

All projects must be related to some aspect of HIV/AIDS research.

In this cycle of grant applications, both domestic applications and applications with international components will be considered. 

Applications are required to indicate how they will work with one or more of the following D-CFAR cores:  Clinical Services, Laboratory Services or the Behavioral and Social Sciences Core.  Please visit the D-CFAR website at http://www.med.miami.edu/dcfar to familiarize yourself with these cores.  

Special notes regarding these awards

●             DCFAR developmental awards cannot support clinical trials as defined by NIAID.  These are studies that involve the administration of a therapeutic or preventive agent.

●             Behavioral studies in humans including interventions will be accepted, but these studies will need to include a DSMP or DSMB, as defined by NIMH policy.  The DCFAR Clinical Services Core can assist you with the formation of a data safety monitoring board. 

          Should your project be considered greater than minimal risk by the IRB, it will need to be approved by the NIH and funds may not be expended from the DCFAR account until this approval has been obtained. This form can be found at http://www3.niaid.nih.gov/research/cfar/docs/CFARClinicalResearchChecklist.doc  

●             Should your project contain an international component, it will it will need to be approved by the NIH and funds may not be expended from the DCFAR account until this approval has been obtained. This form can be found athttp://www3.niaid.nih.gov/research/cfar/docs/CFAR_International_Studies_Checklist.doc

 a) Pilot Projects:

Young faculty investigator in HIV without NIH funding

Faculty new to HIV research that may have NIH funding, but are not funded in the area of AIDS research

Newly recruited faculty in HIV research with or without NIH funding 

b) Innovative Projects, New ideas

New or innovative ideas in HIV research from new investigators and established faculty working in HIV with or without NIH funding.

c) Collaborative projects

Must involve two or more collaborating investigators from different disciplines, and/or different departments or may involve investigators from other institutions. This collaboration should be new and separate from presently funded projects.  Investigators may have current NIH funding for HIV research.  We particularly encourage behavioral science investigators to collaborate with other clinical or basic scientists. 

Grants submitted by women and minorities are encouraged.  Young investigators who may need mentoring or assistance with the grant application process may contact Dr. Gwendolyn Scott for assignment to a mentor.   

Applications should include the following:

1) Project: to include title, principal investigator(s), specific aims, background/preliminary data and experimental plan (maximum of 5 pages).

The following items are not included in the five page limit: 

2) Abstract (Summary of the project and use of D-CFAR core resources)

3) References

4) Listing of D-CFAR core resources and services to be utilized for this project (http://www.med.miami.edu/dcfar)

5) Proposed budget and justification

               a. Proposed expenses should be restricted to laboratory supplies, costs for subject participation, test supplies, small equipment, and technical support. 

              b. Investigator salary, travel and facility expenses should not be included in the budget.

              c. International components will provide reimbursement to their developing countries through an invoicing system as designated by the DCFAR.

6) Biosketch and Other Support in NIH format for the principal investigator and the collaborators.

7) Completion of the appropriate checklists -- listed above for those with more than minimal risk as determined by the IRB.

8) Completion of the attached IRB and Certification for Protection of Human Subjects Form.

9) Please place the investigators name at the top of each page on all forms.

Mentoring/Application Assistance

Mentoring services and assistance in grant writing are offered through the Developmental Core. In particular, young investigators are encouraged to take advantage of these services.  In addition, epidemiology and biostatistical assistance is available through the clinical core.  To access these services, please contact Dr. Gwendolyn B. Scott, Developmental Core Director with your request by email (See address below).

Review Process

Decisions are expected to be made by a scientific review committee headed by Dr. Eckhard Podack by year’s end 2008.   Reviews will be based on scientific merit and the likelihood of attracting NIH or similar funding in the future.  Funding will be awarded based on the grant review score and the availability of funds. The funding period will be for one year from the time of award.

Funding  

Individual applicants may apply for up to $20,000 and collaborative projects may apply for up to $40,000 per project.  Funds will not be released for approved projects until all IRB approvals and certifications have been sent to the DCFAR.  Approval must be approved from the NIH if the grant is considered to be greater than minimal risk to human subjects by the IRB and if the grant has an international component. 

Any questions regarding these applications should be directed to:

Jeanne Tamargo, DCFAR Administrator  Phone (305) 243-8125; Fax (305) 243-7211;Email jtamargo@med.miami.edu

   

We hope to hear from you.

Sincerely,

Gwendolyn B. Scott 

Gwendolyn B. Scott, MD  Director, Developmental Core UM-MSM DCFAR  Phone (305) 243-6522; Fax (305) 243-5562; Email gscott@med.miami.edu.    

 

Gail Shor-Posner

Gail Shor-Posner, PhD  Co-Director, Developmental Core UM-MSM DCFAR  Phone (305) 243-4072; Email gshor-posner@med.miami.edu